α1-adrenoceptor subtype selectivity and organ specificity of silodosin (KMD-3213)

Yakugaku Zasshi

Volumn 126, Issue SPEC. ISS., 2006, Pages 209-216

  Tatemichi, Satoshi ^a   Kobayashi, Kumi ^a   Maezawa, Ayaka ^a   Kobayashi, Mamoru ^a   Yamazaki, Yoshinobu ^a   Shibata, Nobuo ^a  

^a KISSEI PHARMACEUTICAL CO LTD   (Japan)

Author keywords

1A adrenoceptor subtype selectivity; Lower urinary tract; Silodosin (KMD 3213)

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; NAFTOPIDIL; NORADRENALIN; PRAZOSIN; SILODOSIN; TAMSULOSIN; TRITIUM; INDOLE DERIVATIVE;

ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; BLADDER; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; MOUSE STRAIN; NONHUMAN; PROSTATE; RABBIT; RAT; RAT STRAIN; SPLEEN; THORACIC AORTA; URETHRA; ANIMAL; CELL CULTURE; CLASSIFICATION; HUMAN; IN VITRO STUDY; MALE; METABOLISM; MOUSE; MUSCLE CONTRACTION; SPRAGUE DAWLEY RAT; URINARY TRACT;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; CELLS, CULTURED; HUMANS; INDOLES; MALE; MICE; MUSCLE CONTRACTION; NOREPINEPHRINE; ORGAN SPECIFICITY; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-1; URINARY TRACT;

EID: 33645002966     PISSN: 00316903     EISSN: 13475231     Source Type: Journal    
DOI: 10.1248/yakushi.126.209     Document Type: Article

References (22)

1. Hieble J. P., Bylund D. B., Clarke D. E., Eikenburg D. C., Langer S. Z., Lefkowitz R. J., Minneman K. P., Ruffolo Jr. R. R., Pharmacol. Rev., 47, 267-270 (1995).
2. Price D. T., Schwinn D. A., Lomasney J. W., Allen L. F., Caron M. G., Lefkowitz R. J., J. Urol., 50, 546-551 (1993).
3. Nasu K., Moriyama N., Fukasawa R., Tsujimoto G., Tanaka T., Yano J., Kawabe K., Br. J. Pharmacol., 123, 1289-1293 (1998).
4. Walden P. D., Durkin M. M., Lepor H., Wetzel J. M., Gluchowski C., Gustafson E. L., J. Urol., 157, 1032-1038 (1997).
5. Hatano A., Takahashi H., Tamaki M., Komeyama T., Koizumi T., Takeda M., Br. J. Pharmacol., 113, 723-728 (1994).
6. Honda K., Miyata-Osawa A., Takenaka T., Naunyn Schmiedebergs Arch. Pharmacol., 330, 16-21 (1985).
7. Burt R. P., Chapple C. R., Marshall I., Br. J. Pharmacol., 115, 467-475 (1995).
8. Burt R. P., Chapple C. R., Marshall I., Br. J. Pharmacol., 116, 2327-2333 (1995).
9. Kenny B. A., Chalmers D. H., Philpott P. C., Naylor A. M., Br. J. Pharmacol., 115, 981-986 (1995).
10. Arunlakshana O., Schild H. O., Br. J. Pharmacol., 14, 48-58 (1959).
11. Ford A. P., Daniels D. V., Chang D. J., Gever J. R., Jasper J. R., Lesnick J. D., Clarke D. E., Br. J. Pharmacol., 121, 1127-1135 (1997).
12. Testa R., Guarneri L., Angelico P., Poggesi E., Taddei C., Sironi G., Colombo D., Sulpizio A. C., Naselsky D. P., Hieble J. P., Leonardi A., J. Pharmacol. Exp. Ther., 281, 1284-1293 (1997).
13. Yoshio R., Taniguchi T., Itoh H., Muramatsu I., Jpn. J. Pharmacol., 86, 189-195 (2001).
14. Takei R., Ikegaki I., Shibata K., Tsujimoto G., Asano T., Jpn. J. Pharmacol., 79, 447-454 (1999).
15. Yamada S., Suzuki M., Kato Y., Kimura R., Mon R., Matsumoto K., Maruyama M., Kawabe K., Life Sci., 50, 127-135 (1992).
16. Yamagishi R., Akiyama K., Nakamura S., Hora M., Masuda N., Matsuzawa A., Murata S., Ujiie A., Kurashina Y., Iizuka K., Kitazawa M., Eur. J. Pharmacol., 315, 73-79 (1996).
17. Takayanagi I., Konno F., Toru T., Takahashi R., Jpn. J. Pharmacol., 42, 237-241 (1986).
18. Muramatsu I., Ohmura T., Kigoshi S., Hashimoto S., Oshita M., Br. J. Pharmacol., 99, 197-201 (1990).
19. Ford A. P., Williams T. J., Blue D. R., Clarke D. E., Trends Pharmacol. Sci., 15, 167-170 (1994).
20. Langer S. Z., Eur. Urol., 36, 2-6 (1999).
21. Taniguchi N., Ukai Y., Tanaka T., Yano J., Kimura K., Moriyama N., Kawabe K., Naunyn Schmiedebergs Arch. Pharmacol., 355, 412-416 (1997).
22. Hiraoka Y., Ohmura T., Sakamoto S., Hayashi H., Muramatsu I., J. Auton. Pharmacol., 15, 271-278 (1995).